TCW40: Birks are down, women are out of pocket, and Soph might be in for more baggage.

Since entering the stock market with their IPO, Birkenstock have gone from smokin’ hot to a little bit not – but why the fall from grace? Meanwhile, global tech company Klaviyo is sitting pretty after their own IPO – so why the different outcomes? We look at a couple of key questions to help you come to terms with the whos, whats and whys in the world of IPOs. Also, women are out of pocket for healthcare costs (zero surprises there) and Novo Nordisk’s weight loss injections could be changing the shape of the stock market as we know it … but is it too good to be true? For more from The Curve:InstagramWebsiteTikTokNewsletter Disclaimer: Raising The Curve has been prepared solely for informational and educational purposes. Any information provided and serviced described in this website are intended to be of general nature and provide general information only. The opinions expressed by The Curve do not constitute investment advice.